期刊文献+

LC-MS法分析拉米夫定的有关物质 被引量:1

Identification of the related substances in lamivudine by LC-MS
下载PDF
导出
摘要 目的建立检测拉米夫定中有关物质的液质联用分析方法,分析鉴定拉米夫定原料药、加速破坏样品和制剂产品中的有关物质,并推测其可能的降解途径。方法色谱柱为Syncronjs C_(18)柱,以5 mmol·L^(-1)乙酸铵-甲醇为流动相,线性梯度洗脱,对拉米夫定有关物质进行分离。分别在正负离子模式下采用一级全扫描和自动二级全扫描方式对样品进行质谱检测。结果拉米夫定及其各有关物质分离良好,共检测到13种有关物质。结果表明,拉米夫定的主要降解反应为氧化、差向异构化、脱氨和水解。在酸性和高温条件下,药物的稳定性良好,但在碱性和氧化条件下,药物稳定性较差。制剂产品中有关物质的种类较原料药有显著增加。结论该方法适用于拉米夫定有关物质和降解途径的研究,试验中检测到的有关物质,推测的降解途径及该类物质的质谱行为规律为该产品的质量控制及稳定性研究提供了重要的依据。 Objective Objective To develop the LC-MS method for the identification of the related substance of lamivudine in the raw material, accelerated degradation products and the formulation product of lamivudi- ne, and illustrate the proposed degradation pathways of the drug. Methods The chromatographic separation was achieved on a Syncronis C18 column by gradient elution with a mobile phase consisting of 5 mmol·L-1 ammonium acetate solution (A) and methanol (B). The detection was operated by the ion trap mass spec- trometer with the ESI source in the MS and MS/MS full scan mode. Results Good resolution for lamivudine and the related substances was obtained. Total 13 compounds were detected and their structures were elucida- ted. The drug showed instability in alkaline and peroxide while it remained stable to the thermal and acid stress. The results showed that the major degradation pathways of lamivudine were oxidation, epimerization, deamination and hydrolysis. Compared with the raw material, the number of the impurities of the formulation product was increased significantly. Conclusions The method is qualified for the identification of related sub- stance in the lamivudine samples and the research of the degradation pathway of the drug with high sensitivi- ty and efficiency. The results are useful to do research in the quality control of lamivudine products.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2013年第4期256-263,共8页 Journal of Shenyang Pharmaceutical University
关键词 拉米夫定 有关物质 液质联用 lamivudine related substance LC-MS/MS
  • 相关文献

参考文献13

  • 1ICH steering committee. ICH harmonised tripartite guideline: Impurities in new drug products: Q3B (R2) [ EB/OL]. [ 2012- 01 - 09 ]. http://www, ich. org/ fileadmin/Public _ Web _ Site/ICH _ Products/Guide- lines/Quality/Q3B_R2/Step4/Q3B R2 Guideline. pdf.
  • 2ICH steering committee. ICH harmonised tripartite guideline: Impurities in new drug products: Q3 A (R2) [ EB/OL]. [ 2012- 01 - 09 ]. http://www, ich. org/ fileadmin/Public- Web _ Site/ICH _ Products/Guide- lines/Quality/Q3B_R2/Step4/Q3B R2 Guideline.pdf.
  • 3高明,颜晓丹,金松子,蒋庆峰.LC-MS在药物有关物质分析中的应用[J].药物评价研究,2012,35(1):63-66. 被引量:13
  • 4U. S. Department of health and human services (DHHS). Guidelines for the use of antiretroviral a- gents in HIV-l-infected adults and adolescents [ M ]. Washington, D. C. AIDS research advisory council office of DHHS ,January 10, 2000:8 - 9.
  • 5The British Pharmacopoeia Commission. The British Pharmacopoeia 2011 [ M ]. London: the Stationary Of- fice,2010:1270 - 1272.
  • 6European Directorate for the Quality of Medicine. The European Pharmacopoeia 7. 0 [ M ]. Strasbourg (France) : the Directorate for the Quality of Medicine of the Council of Europe,2011:2337 -2339.
  • 7WHO department of essential medicines and pharma- ceutical policies (EMP). The international pharmaco- poeia editiotertia 4th, the second supplement[ S ]. Ge- neva: WHO Press,2011 : lamivudine monograph.
  • 8李萌,刘有平,鲁静,邸欣.RP-HPLC法测定拉米夫定的含量及有关物质[J].药物分析杂志,2009,29(7):1216-1219. 被引量:7
  • 9刁雨辉,刘文一,周建平.拉米夫定片质量比较研究和评价[J].药学与临床研究,2011,19(3):220-223. 被引量:7
  • 10BEDSE G, KUMAR V, SINGH S. Study of forced de- composition behavior of lamivudine using LC, LC- MS/TOF and MSn [ J ]. Pharmaceutical and Biomed- ical Analysis ,2009,49 ( 1 ) .55 - 63.

二级参考文献21

共引文献23

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部